Stem cell regenerative therapy in alveolar cleft reconstruction

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Craniofacial Surgery

Background:

• Craniofacial deformities present significant reconstruction challenges.
• Autologous bone grafting, the current standard for alveolar cleft repair, often yields suboptimal aesthetic and functional outcomes.
• These limitations necessitate the exploration of novel therapeutic strategies.

Purpose of the Study:

• To review recent advancements in mesenchymal stem cell (MSC) tissue engineering for craniofacial bone regeneration.
• To discuss the components of successful stem cell-based strategies, including cell sources, scaffolds, and growth factors.
• To highlight preclinical and clinical evidence supporting stem cell-enhanced bone regeneration.

Main Methods:

• Review of current literature on stem cell-based tissue engineering for craniofacial applications.
• Analysis of studies involving mesenchymal stem cells, biodegradable scaffolds, and osteogenic factors.
• Examination of animal models, case reports, and ongoing clinical trials in the field.

Main Results:

• Mesenchymal stem cell tissue engineering demonstrates potential for improved craniofacial bone regeneration.
• Key elements for success include appropriate stem cell selection, osteoconductive/osteoinductive scaffolds, and growth factor supplementation.
• Preclinical and clinical data suggest efficacy, with ongoing trials further evaluating safety and effectiveness.

Conclusions:

• Mesenchymal stem cell-based tissue engineering represents a promising frontier for treating craniofacial deformities.
• This approach aims to overcome the limitations associated with conventional autologous bone grafting.
• Continued research and clinical trials are crucial for translating these advancements into routine patient care.